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CORRESPONDENCE
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Editor,
Possible health hazards from exposure to trace con-
centrations of inhalational anaesthetics cannot yet be
definitively excluded.1 We have previously reported
that the concentrations of the commonly used volatile
anaesthetic sevoflurane were significantly higher in the
proximity of the intubated patient’s mouth than in
the breathing zone of the surgeon or the far-end corner
of the theatre.2 This observation contradicts the core
function of the cuff, which is to seal the upper airway.
Although previous in-vitro studies highlighted the
possibility of fluid microleakage and its dependence on
intra-cuff pressure,3,4 less is known about whether proper
inflation influences the per oral escape of sevoflurane.
Therefore, the main objective of the present study was
to answer the question whether the concentration of
sevoflurane at the patient’s mouth differed depending
on whether the balloon was inflated under controlled
conditions to 25 to 30 cmH2O using a pressure gauge
or empirically, that is under manual control of the pilot
balloon only.
With institutional ethics approval (DEOEC RKET/
IKET 2483–2006), we included 30 patients undergoing
craniotomy after having given informed consent. In the
first 15 patients, tracheal cuffs were inflated under control
of the Ru¨sch Endotest system setting the intracuff pres-
sure between 25 and 30 cmH2O. In the second 15
patients, tracheal cuffs were inflated empirically, that is
while estimating intracuff pressure based on the hardness
of the pilot balloon. Cuff pressures were measured by an
independent person. All cases used Ru¨schFlex tracheal
tubes with a low-pressure cuff made of polyvinyl chloride
(PVC; Teleflex Medical GmbH, Kernen, Germany)
with sizes of 8.5 and 7.5 for men and women,
respectively. General anaesthesia was performed as
previously outlined in detail.2 During anaesthesia,
we monitored peak pressure, plateau pressure, minute
volume and end-tidal concentration of sevoflurane in
order to explore possible relations to the degree of
anaesthetic escape and thereby obtain hints to the origin
of the release.
For the detection of airborne sevoflurane, we used a
detection set-up that consisted of a portable air sampling
pump (224–51TX Air Sampling Pump; SKC, Dorset,
England), an integrated tube system and an absorber
ampoule coupled to the tube system. The distal part of
the tube was placed in the close proximity of the patient’s
mouth. Cumulative sampling of sevoflurane at the
patient’s mouth was restricted to the period starting from
reaching equilibrium (i.e. when fractions of inhaled and
exhaled are only marginally different) to the beginning of
skin closure. After termination of sample collection, the
ampoule containing the absorber underwent chromato-
graphic assessment by an independent chemist (CP), as
described previously.2 Median sevoflurane concentrations
and balloon pressure were compared using Mann–
Whitney U-test and Student’s unpaired t-test, respect-
ively. Differences were considered statistically signifi-
cant if P<0.05. Calculations were carried out using
Statistica for Windows software (StatSoft, Tulsa,
Oklahoma, USA).
Under controlled conditions, intracuff pressures were suc-
cessfully inflated to a pressure between 25 and 30 cmH2O;
mean [SD], 27.7 [1.9] cmH2O. In contrast, when
cuffs were inflated under manual control, intra-cuff
pressures were found to be higher; 53.0 [17.0] cmH2O
(P<0.001). Median (IQR) concentration of sevoflurane
after inflating the endotracheal cuffs under manometer
control was 1.0W 2.6 ppm, whereas under manual
control was 0.79W 1.49 ppm (PU 0.78). Concentration
of sevoflurane detectable at the patients’ mouth showed
no association with sevoflurane concentration at plateau
pressure (Spearman’s rank correlation coefficient S0.08,
PU 0.63), but did show a significant association with
the end-tidal concentration and the minute volume
of sevoflurane (Spearman’s rank correlation coefficient
0.53 to 0.55, PU 0.003).
The present study highlights that empirically inflated
cuffs may result in intracuff pressures that frequently
exceed the recommended limits of 25 to 30 cmH2O. To
avoid the unwanted impact of high cuff pressures on the
tracheal tissue, cuff inflation should be performed under
guidance of a manometer to ensure an ideal cuff pressure.5
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Moreover, higher cuff pressures do not seem to promote
a more complete sealing of the trachea or decrease
environmental pollution and exposure of staff. Our
observations are in line with previous in-vitro obser-
vations in bench-top models revealing fluid leakage
across the endotracheal cuff even at intraballoon
pressure of 60 cmH2O.
4 This leakage can be ascribed
to the presence of longitudinal folds within the cuff
wall and this is particularly common in cuffs made of
PVC.Major discrepancies between tracheal diameter and
balloon size in the individual patient may increase the
likelihood and number of longitudinal folds in the balloon
wall.6 In further exploring the source of sevoflurane
causing the apparent local increase in its concentration
at the patient’s mouth, we also assessed associations
with various key parameters of the actual ventilation.
The only parameter that could be related to the
sevoflurane concentration at the patient’s mouth was
the end-tidal sevoflurane concentration and the minute
volume, suggesting that the locally increased concen-
tration of the volatile anaesthetic may be linked to the
ventilated lung.
With regard to the potential implications, it is worth
pointing out that sevoflurane concentration at the
patient’s mouth sometimes exceeds the clinically signifi-
cant threshold value of 2 ppm, suggesting that more
investigations into this topic may be warranted.
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Editor,
Ultrasound guidance for central venous catheter (CVC)
access improves patient safety.1 Most studies focus on
the ultrasound-guided needle during venous puncture
employing a short axis view of the internal jugular vein
(IJV).2–4 Further approaches to eliminate the need for a
confirmatory chest radiograph include transthoracic views
to visualise the CVC after placement.2 However, definite
positioning of the CVC in the superior vena cava (SVC)
via a right supraclavicular view has not been evaluated up
to date. The right supraclavicular view was described to
visualise the great intrathoracic vessels including SVC,
pulmonary arteries and ascending aorta.5 We have now
successfully assessed the positioning of a CVC in the SVC
via the right supraclavicular view using a microconvex
probe (8C-RS 4 to 10MHz; GE Healthcare, Munich,
Germany). To our knowledge, this is a novel approach
for CVC placement and allows real-time ultrasound-
guided CVC placement in a definite position in the SVC.
A 87-year-old woman (body weight 120kg, height 140 cm,
BMI 61.2 kgm2) with a history of arterial hypertension
was scheduled for removal of a proximal femur nail. The
patient providedwritten consent for the publication of this
report. General anaesthesia was planned for the surgery
including a CVC placement for postoperative intravenous
antibiotic treatment. Due to unexpected pre-operative
hypokalaemia (2.67mmol l1), it was necessary to prevent
potential arrhythmias being provoked by the CVC guide
wire and the CVC itself. Thus, we employed a microcon-
vex probe for ultrasound-guided puncture of the right IJV
in a short axis view of the carotid triangle and visualisation
of the SVC via the right supraclavicular view following
induction of general anaesthesia, intubation and mechan-
ical ventilation (Fig. 1a–b).Theguidewirewas introduced
into the right IJV and the J-formed guide wire tip was
identified in the right supraclavicular view in the SVC.
Under direct ultrasoundguidance, the tip of the guidewire
was advanced into its final position in the distal part of the
SVC using the ascending aorta and right pulmonary artery
(RPA) as landmarks (Fig. 1c). Anatomically, the RPA
crosses behind the SVC at the cavo-atrial junction.
The CVC was inserted using the Seldinger technique
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until it reached the tip of the guide wire by reading the
guide wire marks. The CVC had a final insertion depth of
14 cm. At this point, the guide wire was removed and the
catheter was sutured at skin level. The patient did not
experience cardiac arrhythmias at any time during the
procedure. Postoperative chest radiograph showed a
correct placement of the CVC in the SVC (Fig. 1d). We
conclude that real-time definite central positioning of a
CVC can be successfully carried out via the right supra-
clavicular view using a suitable ultrasound probe such as a
microconvex or sector probe that allows sufficient tissue
penetration. This novel approach can be conducted by a
single operator in real-time using one single transducer for
venous puncture and CVC positioning.
This concept should be further evaluated in a prospective
observational study comparing ultrasound-guided defi-
nite CVC positioning with chest radiograph, intracardiac
ECG and transesophageal echocardiography for control
of CVC position, respectively. Study operators need to be
trained in proper identification of vascular structures via
the supraclavicular view. This study should also explore
potential limitations of this concept including visibility of
the IJV and sterility considerations.
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(a) Transverse view of common carotid artery (CCA) and internal jugular vein (IJV) with a microconvex probe in the right carotid triangle. (b) Right
supraclavicular view: superior vena cava (SVC), ascending aorta (AAsc), right pulmonary artery (RPA), scale in cm. Note body mark for position of the
ultrasound probe. (c) SVC with J tip of the guide wire. (d) Postoperative chest radiograph with indwelling central venous catheter (CVC) in SVC.
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Editor,
We would like to briefly report on a case of transient
paraplegia that occurred soon after the removal of a
thoracic epidural catheter and resolved spontaneously.
The patient provided informed consent for the publi-
cation of this report.
A 67-year-old woman, weight 43kg, underwent combined
epidural (T10 to T11 catheterisation) and general
anaesthesia for upper oesophageal cancer removal. After
admission to the ICU, due to some bleeding from the
wound, thromboprophylaxis was not administered on the
day of surgery. She received only epoprostenol sodium
5ngkg1min1 intravenously (i.v.) in order to improve the
microcirculation at the colonic anastomotic site. Neither
surgical complications nor signs of liver dysfunction were
detected while in ICU, only mild renal impairment that
occurred in the days following. On the third postoperative
day, epoprostenol was withdrawn and the patient was
transferred to the ward under low molecular weight
heparin (LMWH) prophylaxis (dalteparin 3000 IU per
day). That night the subcutaneous dalteparin was
increased to 5000 IU per day due to immobility, and from
the fourth day, ketorolac 30mg three times daily was also
given. In the absence of abnormalities of both platelet
count and routine coagulation tests, on the fifth day, 14h
after the last dalteparin 5000 IU administration, the
epidural catheter was removed without consulting an
anaesthesiologist. At the timeof epidural catheter removal,
the serum creatinine level was 59.2mol l1, and the
calculated glomerular filtration rate (according to the
Cockcroft-Gault formula) was more than 55mlmin1.
The last dose of ketorolac was administered approxi-
mately 6 h earlier.
A few minutes after catheter removal, the patient com-
plained of severe, persistent pleuritic-like chest pain,
barely responsive to tramadol. Less than 1 h later, she
perceived numbness and loss of muscle strength of both
lower extremities, rapidly followed by flaccid paraplegia.
Neurological examination showed a total loss of mobility
in the left and right lower limbs and an almost complete
sensory deficit reaching to the T10 dermatome (Frankel
Grade A status). MRI, promptly performed, revealed a
large posterior epidural blood collection extending from
T7 to T12, causing displacement and compression of the
spinal cord.
Within a few minutes following the MRI, while waiting
for consultation with the spinal surgeon, she began to
recover, at first from the sensory deficit of the lower limbs
and then gradually also from the motor deficit. At 2h, the
return of normal movement and sensation was complete
(Frankel Grade E status). Careful neurological examin-
ation was carried out later, but no recurrence of sensory or
motor deficit was observed. On the sixth day after
the event, in the complete absence of neurological
impairment, MRI showed a reduction in thickness of
the posterior epidural hematoma from T7 to T12, with
a thin perimedullary liquid film. No compression of the
spinal cord was detected. The patient was then discharged
home with no sequelae.
Thoracic epidural catheterisation is an accepted peri-
operative analgesic technique in patients undergoing oeso-
phagectomy.1 The higher dose of LMWH required in
individuals at a high risk of thrombosis has raised concerns
regarding the increased risk of neuraxial bleeding. Epidural
haematoma formation following catheter removal in
patients receiving LMWH is a well known complication
but seems to be exceptional when it occurs after a
minimum time interval of 10 to 12h following adminis-
tration.2–5 However, renal dysfunction influences LMWH
elimination, and a bioaccumulation of LMWH due to
reduced creatinine clearance in elderly patients with low
lean body mass might affect spontaneous haemostasis.6
In our patient, the association of 5000 IU per day dalteparin
and ketorolac before catheter withdrawal greatly aug-
mented the risk of spinal bleeding. It has been suggested
that LMWH may have a dose-dependent bleeding
potential,7 but a 5000 IU per day dose of dalteparin is
usually recommended in high-risk patients undergoing
major abdominal surgery, irrespective of weight.8
Although the terminal plasma half-life of ketorolac is
approximately in the range of 4 to 6 h, its clearance in this
patient with mild renal insufficiency was most likely
reduced. A significant interaction between ketorolac
and dalteparin to lengthen the bleeding times has been
reported.2,9 In accordance with the recent Nordic guide-
lines for neuraxial blocks in disturbed haemostasis,2
the recommended interval between the last dose
of ketorolac and epidural catheter removal should
be approximately 24 h (Recommendation grade D;
evidence category IV).
Unfortunately, the resident who removed the catheter
was unaware of the potentiation of anticoagulation
induced by NSAIDs in patients receiving LMWH.
The onset of the neurological deficit occurred very
quickly, presumably because the initial bleeding in the
epidural space was considerable enough to induce a very
rapid spinal cord compression. Rapid resolution occurred
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probably because the bleeding was short-lived, allowing
the spread of the initial collection of blood to relieve
the compression. It can also be hypothesised that, due
to an open or partially open spinal canal at the site of
epidural catheterisation (thoracic level), some blood may
have moved out of the epidural space through the inter-
vertebral foramina, thus resolving the compression.
Although early paraplegia has often been reported,
the speed of complete spontaneous recovery from both
sensory and motor deficit appears quite unusual.10,11
Without this, immediate surgery may have been needed.
Given the seriousness of spinal cord injury, care should be
employed in performing regional anaesthesia in renal
impairment with LMWH prophylaxis. Vigilant clinical
judgement and sensible ‘real time’ coagulation tests
are required before removing an epidural catheter in
the presence of renal dysfunction and drugs known to
increase the risk of bleeding.
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Editor,
The intraosseous access is a rather old approach to the
vascular system, but has gained renewed attention during
the last few years and is now considered standard in
special circumstances.1,2 Recent innovative technical
solutions facilitate puncture as compared to the classic
Cook or Jamshidi needles. The currently applicable
resuscitation guidelines state that if intravenous access
cannot be achieved, drugs should be given via the
intraosseous route.1 The EZ-IO system (Vidacare Cor-
poration, San Antonio, TX) was first described in medical
literature in 2004 and has gained wide propagation due
to its ease of use and safety.3,4 A recent meta-analysis
identified extravasation, osteomyelitis, compartment syn-
drome and fractures as possible, but rare, complications.5
We report a previously unencountered complication with
the removal of the EZ-IO intraosseous needle that should
be able to be avoided by strict abidance by the manu-
facturer’s directions for use. It is recommended to con-
nect a Luer-lock syringe to the positioned intraosseous
needle and to apply more rotation than pull onto the
catheter on removal.
In a trauma course demonstration setting, a 38-year-old
male volunteer (one of the authors) agreed to a training
usage of an EZ-IO intraosseous needle. After effortless
and uncomplicated placement on site of the proximal
tibia and test-infusion of a small amount of isotonic
saline, the device was to be removed. Divergent from
the manufacture’s suggestions, the still sterile steel stylet
was put back into place to achieve better grip for a manual
pull-out. Under steady pull in strict axial alignment and
gentle clockwise turn, the needle broke away from the
plastic connector, followed by passive blood emersion
from the still locked needle. Bleeding could be stopped
by intermediate coverage with sterile gauze. The needle
was then carefully and successfully extracted with a pair
of combination pliers and a notable amount of strict axial
force. The volunteer’s tibia is in good shape and shows no
signs of further damage.
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For catheter removal, the company (Vidacare) recom-
mends connecting a Luer-lock syringe and to rotate it
clockwise while using traction.6 It is emphasised that the
catheter should not be rocked or bent during removal. A
careful analysis of the video recording of the removal
manoeuvre revealed no major rocking or bending. More
rotation could have been applied instead of intense pull,
although a visible flick of the remover’s wrist indicates at
least some gyration. The reinsertion of the stylet to
ensure grip might have added rigidity to the catheter
needle, though we presume that Vidacare advises the use
of a syringe, because the stylet will usually have already
been disposed of.
The access to the toolbox of a fire department alleviated
the solution of our problem, but might be inappropriate in
other settings.
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Editor,
We read with interest the article by Espelund et al.1
entitled ‘Analgesic efficacy of ultrasound-guided
adductor canal blockade after arthroscopic anterior cruci-
ate ligament reconstruction: A randomised controlled
trial’. The authors have compared the use of adductor
canal block and multimodal analgesia with multimodal
analgesia alone for analgesia following anterior cruciate
ligament repair with ipsilateral hamstring graft. The
methodology is exemplary and the results are novel in
showing very lowmean pain scores at rest, movement and
standing at 2 h. The study deviates from others in demon-
strating very low pain scores (median VAS of 20mm on
standing at 2 h) with similar levels of dispersion in both
the study groups. Although adductor canal block has been
sparsely evaluated for this surgery, previous studies
evaluating femoral nerve blocks for anterior cruciate
ligament repair have reported higher pain scores than
that noted in the present study and a clear benefit from
blocks.2,3 Dahl et al.4 reported similar pain scores as the
current study without employing blocks wherein they
evaluated COX-2 inhibitors with or without steroids,
combined with a cryo-cuff unlike, the present study.
Although not all patients require blocks for analgesia,
factors predicting their need are still a topic of research
and have even compelled some researchers to develop
models based on machine-learning to predict who would
benefit from them.5
The observed results, although difficult to explain as
elaborated by the authors, the inadequate sample size,
the method of block performance and the presence of a
confounding variable need to be investigated further.
First, the degree of reduction in pain that is clinically
meaningful needs to be decided before choosing the
sample size in order to determine the significance of
nerve blocks. The authors assumed a 50% reduction in
pain scores in the experimental group to be meaningful,
which obviously resulted in a low sample size (22 patients
per group), a skewed distribution and an inability to show
a significant difference between the two groups. If the
authors were to calculate the sample size to achieve a
25 or 30% improvement in pain scores, they would need
99 or 44 patients per group, respectively. What is really
surprising is the very low pain scores noted in either
group. Such pain scores are desirable and make perform-
ance of any regional technique unnecessary. Another
possibility for a lack of difference between the groups
may be the method of performing the block. Also, the
success rate of the block was not tested, which is unusual
in clinical practice. The authors of the study performed
the blocks in the postoperative period; this may not be
possible in the clinical practice due to the presence of
braces and surgical dressings which make appreciation of
anatomical structures difficult.
Bushnell et al.6 did not comment on the site of pain;
the graft donor site can be a significant source of pain
even with an effective femoral nerve block. Hence, in
the presence of a confounding factor such as pain in
the nonblocked area (graft donor site), comparing and
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commenting on pain scores could be misleading. If the
patients requested and received enough analgesics to
achieve pain control at the donor site where the adductor
canal block will have no effect, there will be no diffe-
rence in pain scores or analgesic consumptions. Attractive
strategies to cover the donor site such as a block of the
anterior division of obturator nerve or intramuscular injec-
tions into the donor muscles near the motor end-plate
zones similar to those performed for botulinum toxin
injection7 need to be evaluated. Cumulative rescue anal-
gesic frequency over time would have provided a better
idea about the effect of block on analgesic consumption.
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Editor,
We thank Drs Sondekoppam and Ganapathy for their
interest in our trial and their careful reading thereof.1
As described in our article,2 we were also surprised
about the results revealing very low postoperative pain
scores during the first 24 h after surgery.
We considered a 50% reduction in pain scores in
the intervention group to be clinically relevant. This
threshold was decided before estimating the sample
size and was based on our clinical experience, previous
studies and an assumption of a much higher pain
score than the one observed. On the basis of our results,
we cannot conclude that there is no effect of the
adductor canal blockade; we just have to accept that
the patients in this trial receiving a basic analgesic recipe
of paracetamol and ibuprofen in both groups did not have
sufficient pain to detect an effect of the blockade.
We are aware of the problem about the success rate of
the block not being tested. In order to avoid un-blinding
of the study, no test of sensibility of the lower extremity
(the normal procedure before discharge of patients)
was made. We decided to let the risk of introducing a
potential confounding factor prevail the wish for knowing
the success rate of the performed blocks. We do recom-
mend testing the effect of the adductor canal blockade in
routine care.
As we interpret our data, the major challenge in this
trial was the fact that all patients responded with un-
expectedly low pain scores.
We expected this specific surgical intervention to
cause pain at the hamstring donor site, as well as intra-
articular/periarticular pain. We asked the patients to
evaluate their ‘overall’ pain level (pain related to the
surgical procedure); it would be of no benefit to relieve,
for example, their intraarticular pain only if the
patients were still in pain due to surgical trauma at
the hamstring site. However, ketobemidone consump-
tion in both groups of patients was modest (7.5 vs. 5.0mg
in the control vs. the ropivacaine group, respectively)
during the first 24 h after surgery indicating low pain
levels in general.
Our clinical experience regarding postoperative pain
after anterior cruciate ligament reconstruction prior to
this trial was based on data from different surgeons, and
data from the literature. One surgeon performed the
vast majority of the surgical procedures in our trial.
We therefore must assume that the surgical intervention
performed in the two groups of patients was comparable.
But we also have to consider whether the surgical
technique could have an impact on the degree of
postoperative pain. Maybe it is of importance where
and how the tendon from the sartorius or gracilis
muscle is being harvested; for example whether or not
the periosteum is affected when harvesting the donor
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tendon. Evaluating the outcome of this trial makes
us consider this as a possible important factor for the
observed results.
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Editor,
I have read with great interest the recently published
Editorial on a holistic anaesthesia machine by Professor
Biro.1 The anaesthesia system, described therein, has
been my dream from the day of my very first general
anaesthetic. However, I cannot share Professor Biro’s
faith in the industry to develop such a device, or to
put it maybe a little bit better – to develop it correctly.
If we want it to be a system that can integrate several
drugs from different companies, and at the same
time being able to function in dissimilar anaesthesia
architectures, then there are many conflicts of interests
to be taken into account. Therefore, it is unlikely that
industry itself will produce such a device.
And even if the industry does, there is always the risk
of closed algorithms as it is the case with bispectral index
(BIS) monitors, thereby limiting its usefulness and pre-
venting scientists around the globe from improving them.
I am deeply convinced that we need a new holistic
anaesthesia architecture and that it has to be developed
by a Task Force created by an independent scientific
society such as the European Society of Anaesthesiology.
The Task Force should afterwards also coordinate
and provide funding for further research that would
eventually lead to full implementation of this architec-
ture in a commercially available system. Of course, at this
stage, close cooperation with our industry partners would
be necessary.
The avenues that would open for us if we could imple-
ment such a system in our clinical practice seem huge.
Therefore, I would, once again, plea for a Task Force of
the European Society of Anaesthesiology on this account.
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Editor,
I am delighted to know that there is at least another
dreamer, who understands and supports the rationale
and the necessity for a holistic and independent
anaesthesia system.1 And I am neither surprised nor
offended that my fellow dreamer, Skitek, questions my
faith in the industry to develop such a system. Further-
more, I have to admit that I have been too optimistic so
far, maybe driven by the somewhat naive belief that a
superior system or device might become a reality if there
was an outlook for economic success with it.2 Probably
in this case, more than just a profitable business case is
necessary to trigger the desired progress. My decade-
long, unsuccessful search for an industrial partner in this
respect gives credence to his argument. However, dreams
and hopes have the inbuilt tendency to surprisingly
materialise, even against all odds, after some time.
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As suggested by Skitek the establishment of a task
force in a supranational anaesthesiological body such as
the European Society of Anaesthesiology (ESA) or the
European Society for Computing and Technology in
Anaesthesia and Intensive Care (ESCTAIC) would be
a suitable approach. Let us hope that more voices for
the creation of such a Task Force will be heard in the
future, thus leading to new developments on the ground.
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